

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cysteine metabolic process (GO:0006534) | 5.95684535 |
| 2 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.49101646 |
| 3 | protein K11-linked deubiquitination (GO:0035871) | 4.76982064 |
| 4 | response to nitrosative stress (GO:0051409) | 4.74143332 |
| 5 | response to xenobiotic stimulus (GO:0009410) | 4.55270610 |
| 6 | interleukin-6-mediated signaling pathway (GO:0070102) | 4.24229733 |
| 7 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 4.21788833 |
| 8 | protein heterotetramerization (GO:0051290) | 4.08826161 |
| 9 | negative regulation of T cell differentiation in thymus (GO:0033085) | 4.08502383 |
| 10 | adaptation of signaling pathway (GO:0023058) | 3.88823838 |
| 11 | respiratory chain complex IV assembly (GO:0008535) | 3.79935048 |
| 12 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.70663896 |
| 13 | N-terminal protein amino acid acetylation (GO:0006474) | 3.67016245 |
| 14 | proteasome assembly (GO:0043248) | 3.66027141 |
| 15 | cytidine metabolic process (GO:0046087) | 3.64849512 |
| 16 | cytidine catabolic process (GO:0006216) | 3.64849512 |
| 17 | cytidine deamination (GO:0009972) | 3.64849512 |
| 18 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.64135183 |
| 19 | DNA deamination (GO:0045006) | 3.59388426 |
| 20 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.57770254 |
| 21 | negative regulation of muscle hypertrophy (GO:0014741) | 3.51732278 |
| 22 | regulation of energy homeostasis (GO:2000505) | 3.41087555 |
| 23 | pseudouridine synthesis (GO:0001522) | 3.40005818 |
| 24 | fucose catabolic process (GO:0019317) | 3.37465040 |
| 25 | L-fucose metabolic process (GO:0042354) | 3.37465040 |
| 26 | L-fucose catabolic process (GO:0042355) | 3.37465040 |
| 27 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 3.31611610 |
| 28 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.28495922 |
| 29 | maturation of 5.8S rRNA (GO:0000460) | 3.19942356 |
| 30 | positive regulation of T cell apoptotic process (GO:0070234) | 3.19470398 |
| 31 | cellular response to interleukin-6 (GO:0071354) | 3.18395897 |
| 32 | cytochrome complex assembly (GO:0017004) | 3.16640801 |
| 33 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.15890263 |
| 34 | multicellular organism reproduction (GO:0032504) | 3.15573743 |
| 35 | response to pheromone (GO:0019236) | 3.13110462 |
| 36 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.11536915 |
| 37 | glutathione derivative metabolic process (GO:1901685) | 3.09978282 |
| 38 | glutathione derivative biosynthetic process (GO:1901687) | 3.09978282 |
| 39 | regulation of cellular respiration (GO:0043457) | 3.05878542 |
| 40 | auditory receptor cell stereocilium organization (GO:0060088) | 2.99099110 |
| 41 | glutathione biosynthetic process (GO:0006750) | 2.97397912 |
| 42 | forebrain morphogenesis (GO:0048853) | 2.96164318 |
| 43 | protein-cofactor linkage (GO:0018065) | 2.95029603 |
| 44 | tyrosine metabolic process (GO:0006570) | 2.91980966 |
| 45 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.87608098 |
| 46 | piRNA metabolic process (GO:0034587) | 2.87366845 |
| 47 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.86823072 |
| 48 | galactose metabolic process (GO:0006012) | 2.80555095 |
| 49 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.78243997 |
| 50 | regulation of oxidative stress-induced neuron death (GO:1903203) | 2.76602685 |
| 51 | DNA double-strand break processing (GO:0000729) | 2.75884547 |
| 52 | protein polyglutamylation (GO:0018095) | 2.75767557 |
| 53 | platelet dense granule organization (GO:0060155) | 2.74370753 |
| 54 | tolerance induction (GO:0002507) | 2.73522365 |
| 55 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.73001117 |
| 56 | regulation of thymocyte apoptotic process (GO:0070243) | 2.72469748 |
| 57 | response to interleukin-6 (GO:0070741) | 2.71025005 |
| 58 | interferon-gamma production (GO:0032609) | 2.70658872 |
| 59 | galactose catabolic process (GO:0019388) | 2.68351547 |
| 60 | heart process (GO:0003015) | 2.67573246 |
| 61 | heart contraction (GO:0060047) | 2.67573246 |
| 62 | positive regulation of glycolytic process (GO:0045821) | 2.67012535 |
| 63 | termination of RNA polymerase III transcription (GO:0006386) | 2.65853727 |
| 64 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.65853727 |
| 65 | cellular response to zinc ion (GO:0071294) | 2.65144353 |
| 66 | melanin biosynthetic process (GO:0042438) | 2.64719507 |
| 67 | vesicle fusion (GO:0006906) | 2.64412199 |
| 68 | lactate metabolic process (GO:0006089) | 2.59723917 |
| 69 | negative regulation of mast cell activation (GO:0033004) | 2.59268991 |
| 70 | dopamine transport (GO:0015872) | 2.55913879 |
| 71 | sulfation (GO:0051923) | 2.55103830 |
| 72 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.54881689 |
| 73 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.54768810 |
| 74 | ubiquinone biosynthetic process (GO:0006744) | 2.54502984 |
| 75 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.53777812 |
| 76 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.52674171 |
| 77 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.52674171 |
| 78 | regulation of hippo signaling (GO:0035330) | 2.51399290 |
| 79 | glycolipid biosynthetic process (GO:0009247) | 2.49980497 |
| 80 | rRNA methylation (GO:0031167) | 2.49872978 |
| 81 | behavioral response to nicotine (GO:0035095) | 2.49785633 |
| 82 | intestinal epithelial cell development (GO:0060576) | 2.48093896 |
| 83 | secondary metabolite biosynthetic process (GO:0044550) | 2.46378347 |
| 84 | rRNA modification (GO:0000154) | 2.45546039 |
| 85 | membrane tubulation (GO:0097320) | 2.45197708 |
| 86 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.43446984 |
| 87 | ribosome biogenesis (GO:0042254) | 2.43274621 |
| 88 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.43045445 |
| 89 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.42774571 |
| 90 | S-adenosylmethionine metabolic process (GO:0046500) | 2.42166106 |
| 91 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.42049047 |
| 92 | negative regulation of glycogen metabolic process (GO:0070874) | 2.41947279 |
| 93 | L-phenylalanine catabolic process (GO:0006559) | 2.41614868 |
| 94 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.41614868 |
| 95 | signal peptide processing (GO:0006465) | 2.41171322 |
| 96 | recombinational repair (GO:0000725) | 2.39607387 |
| 97 | double-strand break repair via homologous recombination (GO:0000724) | 2.39526094 |
| 98 | acrosome reaction (GO:0007340) | 2.38944066 |
| 99 | regulation of acrosome reaction (GO:0060046) | 2.37554235 |
| 100 | protein complex biogenesis (GO:0070271) | 2.36036339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.65293201 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 3.46098484 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.16043427 |
| 4 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.84562517 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.69451703 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.60409265 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.49810995 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.40415708 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.37647660 |
| 10 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.25189552 |
| 11 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.04285409 |
| 12 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.99271062 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.98285420 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.98106478 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.94150462 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.92728973 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.91833759 |
| 18 | P300_19829295_ChIP-Seq_ESCs_Human | 1.90367235 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.89175698 |
| 20 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.84089691 |
| 21 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.80307372 |
| 22 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.80307372 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.76637023 |
| 24 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.72450380 |
| 25 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.71183212 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.71125910 |
| 27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.64829383 |
| 28 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.63460688 |
| 29 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.63169485 |
| 30 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.63026981 |
| 31 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.60622801 |
| 32 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.58587344 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.58556707 |
| 34 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.58443979 |
| 35 | FUS_26573619_Chip-Seq_HEK293_Human | 1.58312489 |
| 36 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.56704767 |
| 37 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.55481672 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.54780112 |
| 39 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.54565084 |
| 40 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.54393313 |
| 41 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.52747231 |
| 42 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.48815500 |
| 43 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.47251460 |
| 44 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.46139737 |
| 45 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.42550626 |
| 46 | STAT3_23295773_ChIP-Seq_U87_Human | 1.42470411 |
| 47 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.41449906 |
| 48 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.39065404 |
| 49 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.37347244 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.37209131 |
| 51 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.36568412 |
| 52 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.36554987 |
| 53 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.34598654 |
| 54 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.34598654 |
| 55 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.33361502 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.32510819 |
| 57 | EWS_26573619_Chip-Seq_HEK293_Human | 1.31291472 |
| 58 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.28345827 |
| 59 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.28032887 |
| 60 | TCF4_23295773_ChIP-Seq_U87_Human | 1.26259925 |
| 61 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.25315826 |
| 62 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.23480305 |
| 63 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.23480305 |
| 64 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.22949578 |
| 65 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21650537 |
| 66 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.21311154 |
| 67 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.20791126 |
| 68 | NCOR_22424771_ChIP-Seq_293T_Human | 1.20552093 |
| 69 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.17965355 |
| 70 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.17298498 |
| 71 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14960050 |
| 72 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.14066931 |
| 73 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.13434415 |
| 74 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.11680756 |
| 75 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11367772 |
| 76 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.11329478 |
| 77 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09445223 |
| 78 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.09421023 |
| 79 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08753324 |
| 80 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.08177754 |
| 81 | AR_20517297_ChIP-Seq_VCAP_Human | 1.07274806 |
| 82 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.06929679 |
| 83 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.06686284 |
| 84 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.06552702 |
| 85 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06424272 |
| 86 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.05867124 |
| 87 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05851481 |
| 88 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04889899 |
| 89 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04830467 |
| 90 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.04293733 |
| 91 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.04246198 |
| 92 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.03548963 |
| 93 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03376398 |
| 94 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03286201 |
| 95 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01554239 |
| 96 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.00642054 |
| 97 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.00387517 |
| 98 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.00144539 |
| 99 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99408790 |
| 100 | NFYB_21822215_ChIP-Seq_K562_Human | 0.99164983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006054_spinal_hemorrhage | 5.54960225 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.10516238 |
| 3 | MP0000372_irregular_coat_pigmentation | 4.19207600 |
| 4 | MP0003950_abnormal_plasma_membrane | 3.90236840 |
| 5 | MP0001986_abnormal_taste_sensitivity | 3.14757719 |
| 6 | MP0002653_abnormal_ependyma_morphology | 3.10127235 |
| 7 | MP0003195_calcinosis | 3.01370089 |
| 8 | MP0004084_abnormal_cardiac_muscle | 2.56118502 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.42728175 |
| 10 | MP0005171_absent_coat_pigmentation | 2.25540288 |
| 11 | MP0002102_abnormal_ear_morphology | 2.24597373 |
| 12 | MP0003646_muscle_fatigue | 2.23377668 |
| 13 | MP0003136_yellow_coat_color | 2.17988458 |
| 14 | MP0005075_abnormal_melanosome_morpholog | 2.17373352 |
| 15 | MP0005174_abnormal_tail_pigmentation | 2.14804895 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.07445104 |
| 17 | MP0004147_increased_porphyrin_level | 1.95173293 |
| 18 | MP0004381_abnormal_hair_follicle | 1.93499013 |
| 19 | MP0002095_abnormal_skin_pigmentation | 1.90863059 |
| 20 | MP0005408_hypopigmentation | 1.87959867 |
| 21 | MP0003186_abnormal_redox_activity | 1.84329284 |
| 22 | MP0005551_abnormal_eye_electrophysiolog | 1.82778620 |
| 23 | MP0009785_altered_susceptibility_to | 1.78934973 |
| 24 | MP0005310_abnormal_salivary_gland | 1.76743578 |
| 25 | MP0001764_abnormal_homeostasis | 1.75493027 |
| 26 | MP0004145_abnormal_muscle_electrophysio | 1.75282157 |
| 27 | MP0002938_white_spotting | 1.61225093 |
| 28 | MP0004484_altered_response_of | 1.56432138 |
| 29 | MP0003890_abnormal_embryonic-extraembry | 1.56227827 |
| 30 | MP0000015_abnormal_ear_pigmentation | 1.52632754 |
| 31 | MP0004215_abnormal_myocardial_fiber | 1.51614820 |
| 32 | MP0002163_abnormal_gland_morphology | 1.50922528 |
| 33 | MP0005360_urolithiasis | 1.40988177 |
| 34 | MP0005379_endocrine/exocrine_gland_phen | 1.40093184 |
| 35 | MP0008872_abnormal_physiological_respon | 1.38634403 |
| 36 | MP0005253_abnormal_eye_physiology | 1.38594153 |
| 37 | MP0001485_abnormal_pinna_reflex | 1.36095337 |
| 38 | MP0005410_abnormal_fertilization | 1.35947049 |
| 39 | MP0002254_reproductive_system_inflammat | 1.30858158 |
| 40 | MP0004036_abnormal_muscle_relaxation | 1.27321254 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.26237547 |
| 42 | MP0001853_heart_inflammation | 1.25579155 |
| 43 | MP0001348_abnormal_lacrimal_gland | 1.25552851 |
| 44 | MP0003011_delayed_dark_adaptation | 1.24731483 |
| 45 | MP0005423_abnormal_somatic_nervous | 1.12984635 |
| 46 | MP0003943_abnormal_hepatobiliary_system | 1.12616298 |
| 47 | MP0003878_abnormal_ear_physiology | 1.09867573 |
| 48 | MP0005377_hearing/vestibular/ear_phenot | 1.09867573 |
| 49 | MP0008058_abnormal_DNA_repair | 1.09346326 |
| 50 | MP0003279_aneurysm | 1.06836961 |
| 51 | MP0005332_abnormal_amino_acid | 1.03460995 |
| 52 | MP0008775_abnormal_heart_ventricle | 1.02555072 |
| 53 | MP0003252_abnormal_bile_duct | 0.99386782 |
| 54 | MP0001501_abnormal_sleep_pattern | 0.98139178 |
| 55 | MP0001790_abnormal_immune_system | 0.96672205 |
| 56 | MP0005387_immune_system_phenotype | 0.96672205 |
| 57 | MP0002160_abnormal_reproductive_system | 0.92480117 |
| 58 | MP0000371_diluted_coat_color | 0.91026699 |
| 59 | MP0001984_abnormal_olfaction | 0.89121269 |
| 60 | MP0001529_abnormal_vocalization | 0.86756327 |
| 61 | MP0002272_abnormal_nervous_system | 0.86752201 |
| 62 | MP0002933_joint_inflammation | 0.86621768 |
| 63 | MP0002693_abnormal_pancreas_physiology | 0.85758346 |
| 64 | MP0006082_CNS_inflammation | 0.82775751 |
| 65 | MP0000427_abnormal_hair_cycle | 0.82750677 |
| 66 | MP0005671_abnormal_response_to | 0.82535185 |
| 67 | MP0005389_reproductive_system_phenotype | 0.82002874 |
| 68 | MP0006276_abnormal_autonomic_nervous | 0.81091240 |
| 69 | MP0009780_abnormal_chondrocyte_physiolo | 0.79870194 |
| 70 | MP0001873_stomach_inflammation | 0.78235922 |
| 71 | MP0002876_abnormal_thyroid_physiology | 0.77566947 |
| 72 | MP0005623_abnormal_meninges_morphology | 0.77157678 |
| 73 | MP0006036_abnormal_mitochondrial_physio | 0.74641543 |
| 74 | MP0001915_intracranial_hemorrhage | 0.74468816 |
| 75 | MP0003718_maternal_effect | 0.74416280 |
| 76 | MP0006072_abnormal_retinal_apoptosis | 0.73225467 |
| 77 | MP0003633_abnormal_nervous_system | 0.72499747 |
| 78 | MP0001968_abnormal_touch/_nociception | 0.71116351 |
| 79 | MP0001800_abnormal_humoral_immune | 0.68772286 |
| 80 | MP0005647_abnormal_sex_gland | 0.68385144 |
| 81 | MP0005266_abnormal_metabolism | 0.68287385 |
| 82 | MP0002148_abnormal_hypersensitivity_rea | 0.67825950 |
| 83 | MP0003045_fibrosis | 0.66750564 |
| 84 | MP0001324_abnormal_eye_pigmentation | 0.65863802 |
| 85 | MP0004142_abnormal_muscle_tone | 0.64303961 |
| 86 | MP0008877_abnormal_DNA_methylation | 0.64215831 |
| 87 | MP0000230_abnormal_systemic_arterial | 0.63126041 |
| 88 | MP0009046_muscle_twitch | 0.61947976 |
| 89 | MP0003936_abnormal_reproductive_system | 0.61180570 |
| 90 | MP0000749_muscle_degeneration | 0.60315731 |
| 91 | MP0010155_abnormal_intestine_physiology | 0.59779016 |
| 92 | MP0002723_abnormal_immune_serum | 0.58490656 |
| 93 | MP0004742_abnormal_vestibular_system | 0.57418256 |
| 94 | MP0002736_abnormal_nociception_after | 0.57366775 |
| 95 | MP0005376_homeostasis/metabolism_phenot | 0.57171043 |
| 96 | MP0008789_abnormal_olfactory_epithelium | 0.55723614 |
| 97 | MP0001929_abnormal_gametogenesis | 0.55553882 |
| 98 | MP0009745_abnormal_behavioral_response | 0.54981074 |
| 99 | MP0002972_abnormal_cardiac_muscle | 0.54155246 |
| 100 | MP0002735_abnormal_chemical_nociception | 0.53760096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic hepatic failure (HP:0100626) | 5.94199181 |
| 2 | Progressive inability to walk (HP:0002505) | 4.47792736 |
| 3 | Congenital stationary night blindness (HP:0007642) | 4.39706182 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 3.57380809 |
| 5 | Acute encephalopathy (HP:0006846) | 3.56437483 |
| 6 | Aplastic anemia (HP:0001915) | 3.33701263 |
| 7 | Progressive macrocephaly (HP:0004481) | 3.22100304 |
| 8 | Pancreatic cysts (HP:0001737) | 3.21048503 |
| 9 | Abnormality of midbrain morphology (HP:0002418) | 3.18028383 |
| 10 | Molar tooth sign on MRI (HP:0002419) | 3.18028383 |
| 11 | Mitochondrial inheritance (HP:0001427) | 3.16790057 |
| 12 | Inability to walk (HP:0002540) | 3.14558144 |
| 13 | Congenital sensorineural hearing impairment (HP:0008527) | 3.03595912 |
| 14 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.99144792 |
| 15 | Absent/shortened dynein arms (HP:0200106) | 2.99144792 |
| 16 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.93884886 |
| 17 | Increased CSF lactate (HP:0002490) | 2.92617294 |
| 18 | Increased hepatocellular lipid droplets (HP:0006565) | 2.82857753 |
| 19 | Hypoplasia of the fovea (HP:0007750) | 2.78695136 |
| 20 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.78695136 |
| 21 | Lipid accumulation in hepatocytes (HP:0006561) | 2.77577015 |
| 22 | True hermaphroditism (HP:0010459) | 2.74472983 |
| 23 | Hepatocellular necrosis (HP:0001404) | 2.72936599 |
| 24 | Type 2 muscle fiber atrophy (HP:0003554) | 2.68691242 |
| 25 | Posterior subcapsular cataract (HP:0007787) | 2.67247621 |
| 26 | Popliteal pterygium (HP:0009756) | 2.59084538 |
| 27 | Pancreatic fibrosis (HP:0100732) | 2.52421424 |
| 28 | Horizontal nystagmus (HP:0000666) | 2.50258195 |
| 29 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.47242222 |
| 30 | Attenuation of retinal blood vessels (HP:0007843) | 2.43594404 |
| 31 | Chorioretinal atrophy (HP:0000533) | 2.39595721 |
| 32 | Optic disc pallor (HP:0000543) | 2.37637944 |
| 33 | Abnormal gallbladder physiology (HP:0012438) | 2.37131172 |
| 34 | Cholecystitis (HP:0001082) | 2.37131172 |
| 35 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.36959169 |
| 36 | Tubular atrophy (HP:0000092) | 2.35795973 |
| 37 | Hypoproteinemia (HP:0003075) | 2.34570983 |
| 38 | Stomatitis (HP:0010280) | 2.32909112 |
| 39 | Gaze-evoked nystagmus (HP:0000640) | 2.31580537 |
| 40 | Abnormality of placental membranes (HP:0011409) | 2.31029887 |
| 41 | Amniotic constriction ring (HP:0009775) | 2.31029887 |
| 42 | Medial flaring of the eyebrow (HP:0010747) | 2.30212955 |
| 43 | Ketoacidosis (HP:0001993) | 2.28676731 |
| 44 | Decreased central vision (HP:0007663) | 2.27421581 |
| 45 | Nephronophthisis (HP:0000090) | 2.22878029 |
| 46 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.20644527 |
| 47 | Increased serum lactate (HP:0002151) | 2.18782051 |
| 48 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.16289217 |
| 49 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.16289217 |
| 50 | Type II lissencephaly (HP:0007260) | 2.14018643 |
| 51 | Chromsome breakage (HP:0040012) | 2.13314871 |
| 52 | Hepatic necrosis (HP:0002605) | 2.12208305 |
| 53 | Chronic sinusitis (HP:0011109) | 2.10823715 |
| 54 | Mutism (HP:0002300) | 2.10795869 |
| 55 | Renal Fanconi syndrome (HP:0001994) | 2.09636258 |
| 56 | Abnormality of the fovea (HP:0000493) | 2.08735723 |
| 57 | Dyschromatopsia (HP:0007641) | 2.06690697 |
| 58 | Abnormality of alanine metabolism (HP:0010916) | 2.03902683 |
| 59 | Hyperalaninemia (HP:0003348) | 2.03902683 |
| 60 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.03902683 |
| 61 | Hypergonadotropic hypogonadism (HP:0000815) | 2.01915978 |
| 62 | Abnormal ciliary motility (HP:0012262) | 1.95486715 |
| 63 | Cerebral edema (HP:0002181) | 1.95297805 |
| 64 | Spastic paraparesis (HP:0002313) | 1.95148937 |
| 65 | Muscle fiber atrophy (HP:0100295) | 1.94926260 |
| 66 | Median cleft lip (HP:0000161) | 1.92115063 |
| 67 | Loss of speech (HP:0002371) | 1.91790486 |
| 68 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.88551833 |
| 69 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.87862066 |
| 70 | Abnormality of the renal medulla (HP:0100957) | 1.86367868 |
| 71 | Abolished electroretinogram (ERG) (HP:0000550) | 1.83535383 |
| 72 | Constricted visual fields (HP:0001133) | 1.83433966 |
| 73 | Severe visual impairment (HP:0001141) | 1.83392106 |
| 74 | Pendular nystagmus (HP:0012043) | 1.80426068 |
| 75 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.80103225 |
| 76 | Abnormal number of erythroid precursors (HP:0012131) | 1.78024068 |
| 77 | Chronic otitis media (HP:0000389) | 1.77769415 |
| 78 | Cystic liver disease (HP:0006706) | 1.77504645 |
| 79 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.76667538 |
| 80 | Abnormality of DNA repair (HP:0003254) | 1.76377687 |
| 81 | Concave nail (HP:0001598) | 1.76184682 |
| 82 | Male pseudohermaphroditism (HP:0000037) | 1.74717106 |
| 83 | Exertional dyspnea (HP:0002875) | 1.74376372 |
| 84 | Metaphyseal dysplasia (HP:0100255) | 1.74357374 |
| 85 | Nephrogenic diabetes insipidus (HP:0009806) | 1.74088476 |
| 86 | Hypothermia (HP:0002045) | 1.73815254 |
| 87 | Bulbous nose (HP:0000414) | 1.72852969 |
| 88 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.71383731 |
| 89 | Congenital primary aphakia (HP:0007707) | 1.70626116 |
| 90 | Rhinitis (HP:0012384) | 1.69704700 |
| 91 | Neonatal respiratory distress (HP:0002643) | 1.69568093 |
| 92 | Birth length less than 3rd percentile (HP:0003561) | 1.69533587 |
| 93 | Thyroiditis (HP:0100646) | 1.69128483 |
| 94 | Albinism (HP:0001022) | 1.67695165 |
| 95 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.67008917 |
| 96 | Genetic anticipation (HP:0003743) | 1.65913328 |
| 97 | Decreased circulating renin level (HP:0003351) | 1.64416177 |
| 98 | Abnormality of the pons (HP:0007361) | 1.63908019 |
| 99 | Dyskinesia (HP:0100660) | 1.63576164 |
| 100 | Tachypnea (HP:0002789) | 1.62304665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PASK | 4.96427327 |
| 2 | TXK | 3.98411252 |
| 3 | FRK | 3.23312313 |
| 4 | BMPR1B | 3.19038576 |
| 5 | NEK1 | 3.18648798 |
| 6 | MAP3K13 | 3.13029898 |
| 7 | MST4 | 2.65521388 |
| 8 | ACVR1B | 2.61982508 |
| 9 | NUAK1 | 2.42149377 |
| 10 | EIF2AK3 | 2.33221030 |
| 11 | EIF2AK1 | 2.29355408 |
| 12 | CAMKK1 | 2.06047733 |
| 13 | MAP3K12 | 2.03762186 |
| 14 | STK38L | 2.02968869 |
| 15 | TRIM28 | 1.99262132 |
| 16 | VRK2 | 1.96047885 |
| 17 | BRSK2 | 1.90412908 |
| 18 | GRK1 | 1.82890691 |
| 19 | MUSK | 1.70422801 |
| 20 | ADRBK2 | 1.68916844 |
| 21 | LATS1 | 1.53506264 |
| 22 | FER | 1.52591110 |
| 23 | MAP4K2 | 1.46317408 |
| 24 | STK39 | 1.46003089 |
| 25 | MAPKAPK3 | 1.35449242 |
| 26 | OXSR1 | 1.31049088 |
| 27 | CASK | 1.30230029 |
| 28 | NME1 | 1.30198844 |
| 29 | IKBKB | 1.28135351 |
| 30 | INSRR | 1.25487781 |
| 31 | MKNK2 | 1.21117475 |
| 32 | TAOK3 | 1.19198278 |
| 33 | PAK3 | 1.17347711 |
| 34 | GRK5 | 1.09184386 |
| 35 | WNK4 | 1.08934655 |
| 36 | SIK3 | 1.07602564 |
| 37 | TAF1 | 0.98363371 |
| 38 | PDK2 | 0.93214578 |
| 39 | ZAK | 0.92458195 |
| 40 | WNK3 | 0.91045019 |
| 41 | TGFBR1 | 0.90999961 |
| 42 | TIE1 | 0.87204237 |
| 43 | ADRBK1 | 0.83768675 |
| 44 | PLK2 | 0.83502911 |
| 45 | BCR | 0.82650517 |
| 46 | CSNK1A1L | 0.82305706 |
| 47 | MST1R | 0.82300022 |
| 48 | WEE1 | 0.80512793 |
| 49 | MAPKAPK5 | 0.79443319 |
| 50 | DAPK1 | 0.78369562 |
| 51 | TSSK6 | 0.76120186 |
| 52 | CSNK1G3 | 0.74250669 |
| 53 | MARK3 | 0.73428444 |
| 54 | PLK3 | 0.72193011 |
| 55 | VRK1 | 0.71525856 |
| 56 | DAPK2 | 0.69364931 |
| 57 | MAP3K14 | 0.68923496 |
| 58 | MYLK | 0.68257945 |
| 59 | EIF2AK2 | 0.66887295 |
| 60 | PRKCQ | 0.63999184 |
| 61 | AKT3 | 0.63815431 |
| 62 | MKNK1 | 0.63166863 |
| 63 | MAP4K1 | 0.60768443 |
| 64 | CAMKK2 | 0.60059726 |
| 65 | PINK1 | 0.59175901 |
| 66 | CHUK | 0.58928269 |
| 67 | MAP3K3 | 0.58253713 |
| 68 | PRKCI | 0.57823940 |
| 69 | CSNK1G1 | 0.56993248 |
| 70 | CSNK1G2 | 0.56978079 |
| 71 | DYRK2 | 0.54603292 |
| 72 | ITK | 0.53816137 |
| 73 | BRSK1 | 0.52036355 |
| 74 | MAPK13 | 0.49511738 |
| 75 | PTK2B | 0.48157708 |
| 76 | GRK7 | 0.46731238 |
| 77 | STK38 | 0.46687673 |
| 78 | CLK1 | 0.46229416 |
| 79 | TEC | 0.46005914 |
| 80 | ERBB3 | 0.45534223 |
| 81 | TNIK | 0.43570193 |
| 82 | CCNB1 | 0.41915117 |
| 83 | LRRK2 | 0.39482396 |
| 84 | NEK6 | 0.39384275 |
| 85 | STK3 | 0.38523902 |
| 86 | NLK | 0.36944289 |
| 87 | PIK3CG | 0.36425491 |
| 88 | PAK6 | 0.35935808 |
| 89 | MAP2K1 | 0.35183728 |
| 90 | PLK4 | 0.34907595 |
| 91 | IGF1R | 0.34290906 |
| 92 | PRKAA2 | 0.32587032 |
| 93 | MELK | 0.30963117 |
| 94 | ABL2 | 0.28863238 |
| 95 | LCK | 0.27871684 |
| 96 | PRKCE | 0.26933651 |
| 97 | STK10 | 0.25113091 |
| 98 | TNK2 | 0.24648894 |
| 99 | TGFBR2 | 0.24043236 |
| 100 | PIK3CA | 0.23739992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.81033327 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.44915575 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.13186778 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.04570800 |
| 5 | Phototransduction_Homo sapiens_hsa04744 | 2.64000265 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.53105315 |
| 7 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.37957967 |
| 8 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.20975626 |
| 9 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 2.17088437 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.11688879 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.03714483 |
| 12 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.03045200 |
| 13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.98845633 |
| 14 | RNA polymerase_Homo sapiens_hsa03020 | 1.88939317 |
| 15 | Basal transcription factors_Homo sapiens_hsa03022 | 1.79041965 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.76313123 |
| 17 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.71824605 |
| 18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.52492699 |
| 19 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.50257112 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.49857884 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.49167801 |
| 22 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.48830281 |
| 23 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.43369359 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.42499194 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.42364764 |
| 26 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.41482463 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.40956691 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39293092 |
| 29 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.32265243 |
| 30 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.31682807 |
| 31 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.29833346 |
| 32 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.29492360 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27321553 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24900080 |
| 35 | RNA degradation_Homo sapiens_hsa03018 | 1.23240258 |
| 36 | Parkinsons disease_Homo sapiens_hsa05012 | 1.21413075 |
| 37 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.21334567 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.20046805 |
| 39 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.16515220 |
| 40 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.10252882 |
| 41 | Ribosome_Homo sapiens_hsa03010 | 1.09023535 |
| 42 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.08452367 |
| 43 | Olfactory transduction_Homo sapiens_hsa04740 | 1.02740486 |
| 44 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.01282214 |
| 45 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.94689753 |
| 46 | Purine metabolism_Homo sapiens_hsa00230 | 0.93840016 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92465291 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90668934 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.89617637 |
| 50 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.87803076 |
| 51 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.82289234 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.80063035 |
| 53 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.79890270 |
| 54 | Mineral absorption_Homo sapiens_hsa04978 | 0.79556374 |
| 55 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79048746 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.74821009 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.74696025 |
| 58 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.74181913 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.71681252 |
| 60 | Allograft rejection_Homo sapiens_hsa05330 | 0.71311985 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71019591 |
| 62 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.70489987 |
| 63 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70143944 |
| 64 | RNA transport_Homo sapiens_hsa03013 | 0.69913114 |
| 65 | Metabolic pathways_Homo sapiens_hsa01100 | 0.69812589 |
| 66 | Taste transduction_Homo sapiens_hsa04742 | 0.68979086 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68416557 |
| 68 | Huntingtons disease_Homo sapiens_hsa05016 | 0.67982476 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.64896095 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.63422091 |
| 71 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59578380 |
| 72 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58571096 |
| 73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57838910 |
| 74 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.55897520 |
| 75 | Alzheimers disease_Homo sapiens_hsa05010 | 0.55318362 |
| 76 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52227543 |
| 77 | Measles_Homo sapiens_hsa05162 | 0.51712564 |
| 78 | Morphine addiction_Homo sapiens_hsa05032 | 0.51384986 |
| 79 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.49799794 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48776077 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46454717 |
| 82 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45515085 |
| 83 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.45458263 |
| 84 | Legionellosis_Homo sapiens_hsa05134 | 0.44889437 |
| 85 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.44489637 |
| 86 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43819930 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43654046 |
| 88 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.42667315 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41190555 |
| 90 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.41032678 |
| 91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40452375 |
| 92 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.40446481 |
| 93 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.39897871 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39271118 |
| 95 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38624573 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36850654 |
| 97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35635147 |
| 98 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.33599605 |
| 99 | Nicotine addiction_Homo sapiens_hsa05033 | 0.33561824 |
| 100 | Salivary secretion_Homo sapiens_hsa04970 | 0.32921170 |

